Related Experiment Video
Updated: Feb 3, 2026

Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment
Published on: February 22, 2017
Optimal duration of antibiotic treatment in Gram-negative infections
Jan J De Waele1, Ignacio Martin-Loeches2
1Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.
Purpose Of Review:
Whilst many guidelines recommend limiting the use of antibiotics because of the increase in antimicrobial resistance (AMR), this strategy becomes challenging when dealing with severe infections in critically ill patients. Moreover, some Gram-negative bacilli (GNB) can exhibit mechanisms of resistance that make the patient more vulnerable to recurrence of infections. We reviewed recent data on the optimal duration of antibiotic therapy in these patients.
Recent Findings:
Apart from having no additional clinical benefit at a certain point after initiation, antibiotics might have negative effects. Prolonged antibiotic exposure has been associated to development of AMR and represents a strong reason to avoid long courses of antibiotic therapy in GNB infections. Recent data suggest that also patients with severe infections, in whom source control is adequate, can be managed with short-course antibiotic therapy.
Summary:
The optimal duration of antibiotic therapy depends on many factors, but overall, many infections in the critically ill can be treated with short-course antibiotic therapy (7 days or less). The integration of signs of resolution, biomarkers, clinical judgment, and microbiologic eradication might help to define this optimal duration in patients with life-threatening infections caused by GNB.
Insights
Short-course antibiotic therapy, 7 days or less, is effective for severe Gram-negative bacilli infections in critically ill patients. This approach helps combat antimicrobial resistance (AMR) without compromising patient outcomes.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pharmacology
Background:
- Antimicrobial resistance (AMR) necessitates limiting antibiotic use, posing challenges in treating severe infections in critically ill patients.
- Gram-negative bacilli (GNB) infections can lead to recurrent infections due to resistance mechanisms.
- Optimal antibiotic duration is crucial for balancing treatment efficacy and minimizing resistance development.
Purpose of the Study:
- To review recent data on the optimal duration of antibiotic therapy for severe infections caused by Gram-negative bacilli (GNB) in critically ill patients.
- To evaluate the feasibility of short-course antibiotic therapy in managing GNB infections.
- To identify factors influencing the optimal duration of antibiotic treatment.
Main Methods:
- Review of recent scientific literature and clinical data.
- Analysis of studies investigating antibiotic therapy duration for severe GNB infections.
- Evaluation of clinical outcomes and antimicrobial resistance patterns.
Main Results:
- Prolonged antibiotic exposure can lead to AMR and offers no additional clinical benefit beyond a certain point.
- Short-course antibiotic therapy (7 days or less) is effective for many GNB infections in critically ill patients with adequate source control.
- Factors like resolution of infection signs, biomarkers, clinical judgment, and microbiologic eradication aid in determining optimal duration.
Conclusions:
- Short-course antibiotic therapy is a viable option for severe GNB infections in critically ill patients.
- Careful integration of clinical and microbiological data can help define optimal antibiotic duration.
- Limiting antibiotic exposure through shorter courses is essential for combating AMR.
Related Concept Videos
Gram-negative Bacterial Protein Secretion Systems
Antibiotic Selection
Negative Regulator Molecules
Positive, Negative, and Zero Work
Optimal Foraging
Development of Antibiotic Resistance

